Injecting alone among young adult IDUs in five US cities: Evidence of low rates of injection risk behavior

Drug and Alcohol Dependence

Volumn 91, Issue SUPPL. 1, 2007, Pages

  Hagan, Holly ^a   Campbell, Jennifer V ^b   Thiede, Hanne ^b   Strathdee, Steffanie A ^c   Ouellet, Lawrence ^d   Latka, Mary ^e   Hudson, Sharon ^f   Garfein, Richard S ^c  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b Public Health Seattle and King County   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e NEW YORK ACADEMY OF MEDICINE   (United States)

^f Health Research Association   (United States)

Author keywords

HCV; Hepatitis; HIV; Injection drug use; Policy; Prevention; Risk behavior; Substance use

Indexed keywords

ILLICIT DRUG;

ACCIDENTAL DEATH; ADOLESCENT; ADULT; ARTICLE; CITY; DRUG OVERDOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SYRINGE; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; ODDS RATIO; QUESTIONNAIRES; RISK-TAKING; SEX FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; URBAN POPULATION;

HEPATITIS C VIRUS;

EID: 34648835639     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.02.002     Document Type: Article

References (26)

1. Courtwright D., Joseph H., and Des Jarlais D.C. Addicts who Survived: An Oral History of Narcotic Use in America, 1923-1965 (1989), University of Tennessee Press, Knoxville
2. Crofts N., Nigro L., Oman K., Stevenson D., and Sherman J. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 92 (1997) 999-1005
3. Curtis R., Friedman S.R., Neaigus A., Jose B., Goldstein M.F., and Ildefonso G. Street-level drug markets: network structure and HIV risk. Social Networks 17 (1995) 229-249
4. Davidson P.J., McLean R.L., Kral A.H., Gleghorn A.A., Edlin B.R., and Moss A.R. Fatal heroin-related overdose in San Francisco, 1997-2000: a case for targeted intervention. J. Urban Health 80 (2003) 261-273
5. Derogatis L.R., and Milisaratos N. The brief symptom inventory: an introductory report. Psych. Med. 13 (1983) 595-605
6. Des Jarlais D.C., Diaz T., Perlis T., Vlahov D., Maslow C., Latka M., Rockwell R., Edwards V., Friedman S.R., Monterroso E., Williams I., and Garfein R. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 157 (2003) 467-471
7. Diaz T., Des Jarlais D.C., Vlahov D., Perlis T.E., Edwards V., Friedman S.R., Rockwell R., Hoover D., Williams I.T., and Monterroso E. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am. J. Public Health 91 (2001) 23-30
8. Evans J.L., Hahn J.A., Page-Shafer K., Lum P.J., Stein E.S., Davidson P.J., and Moss A.R. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J. Urban Health 80 (2003) 137-146
9. Friedman S.R., Maslow C., Bolyard M., Sandoval M., Mateu-Gelabert P., and Neaigus A. Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Educ. Prevent. 16 (2004) 250-263
10. Garfein R.S., Schwartzendruber A., Ouellet L., Kapadia F., Hudson S., Thiede H., Strathdee S.A., Williams I., Bailey S., Hagan H., Golub E., Kerndt P., Hanson D., Latka M., and for the DUIT Study Team. Methods for a small-group behavioral intervention trial for the primary prevention of HIV and hepatitis C virus infection associated risk behaviors: The CIDUS III/DUIT Study. Drug Alc. Depend. 91 Suppl. 1 (2007) S4-S17
11. Hagan H., Thiede H., Weiss N.S., Hopkins S., Duchin J., and Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
12. Hagan H., Des Jarlais D.C., Friedman S.R., Purchase D., and Alter M.J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am. J. Public Health 85 (1995) 1531-1537
13. Hagan H., McGough J.P., Thiede H., Weiss N.S., Hopkins S., and Alexander E.R. Syringe exchange and risk of infection with hepatitis B and C viruses. Am. J. Epidemiol. 149 (1999) 203-213
14. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., and Moss A.R. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. J. Infect. Dis. 186 (2002) 1558-1564
15. Hunter G.M., Stimson G.V., Judd A., Jones S., and Hickman M. Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. Addiction 95 (2000) 1351-1361
16. Judd A., Hickman M., Jones S., McDonald T., Parry J.V., Stimson J.V., and Hall A.J. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ 330 (2005) 24-25
17. Kapadia F., Vlahov D., Des Jarlais D.C., Strathdee S.A., Ouellet L., Kerndt P., Morse E.V., Williams I., and Garfein R.S. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users?. Epidemiology 13 (2002) 738-741
18. Koester S., Glanz J., and Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 9 (2005) 27-39
19. Neaigus A., Friedman S.R., Curtis R., Des Jarlais D.C., Furst R.T., Jose B., Mota P., Stepherson B., Sufian M., and Ward T. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc. Sci. Med. 38 (1994) 67-78
20. Novelli L.A., Sherman S.G., Havens J.R., Strathdee S.A., and Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend. 77 (2005) 303-309
21. Ompad D.C., Fuller C.M., Vlahov D., Thomas D., and Strathdee S.A. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin. Infect. Dis. 35 (2002) 783-788
22. Rezza G., Sagliocca L., Zaccarelli M., Nespoli M., Siconofli M., and Baldasarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand. J. Infect. Dis. 28 (1996) 27-29
23. Rhodes T., Davis M., and Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 99 (2004) 621-633
24. Rosenberg M. Society and the Adolescent Self-image. Revised ed. (1989), Wesleyan University Press, Middletown, CT
25. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., Monterroso E.R., and Garfein R.S. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 155 (2002) 645-653
26. van Beek I., Buckley R., Stewart M., MacDonald M., and Kaldor J. Risk factors for hepatitis C virus infection among injecting drug users in Sydney. Genitourin Med. 70 (1994) 321-324